Tectonic Therapeutic reported $239.89M in Current Assets for its fiscal quarter ending in March of 2026.





Current Assets Change Date
Akebia Therapeutics USD 243.48M 9.47M Mar/2026
Alnylam Pharmaceuticals USD 4.62B 400.86M Jun/2026
Celltrion KRW 481.57B 10.97B Mar/2026
Cspc Pharmaceutical CNY 22.25B 359.48M Dec/2025
Deva Holding AS TRY 9.13B 1.61B Sep/2023
Dianthus Therapeutics USD 897.54M 222.37M Jun/2026
Divis Laboratories Ltd INR 110.96B 12.53B Mar/2026
Gilead Sciences USD 18.64B 1.25B Mar/2026
Ionis Pharmaceuticals USD 2.49B 446.73M Jun/2026
Kangmei Pharma CNY 6.8B 225.83M Mar/2026
Karyopharm Therapeutics USD 126.33M 23.19M Mar/2026
Knight Therapeutics CAD 394.84M 5.86M Dec/2025
Laboratorios Farma EUR 509.33M 128.63M Dec/2023
MacroGenics USD 182.52M 37.42M Mar/2026
Malin Corporation EUR 62.6M 26.7M Dec/2024
Medical Developments International AUD 33.75M 1.79M Dec/2025
Neuren Pharmaceuticals AUD 332.23M 11.98M Dec/2025
Organigram Holdings CAD 250.09M 6.46M Mar/2026
Ovoca Bio EUR 2.07M 510K Dec/2025
Pfizer USD 41.36B 1.46B Jun/2026
Pharma Mar EUR 280.95M 7.5M Jun/2026
Qiagen NV USD 1.54B 454.82M Mar/2026
Roche Holding CHF 35.44B 3.29B Jun/2026
Sangamo BioSciences USD 49.89M 12.3M Jun/2025
Sanofi EUR 31.52B 1.36B Jun/2026
Sarepta Therapeutics USD 2.31B 228.06M Mar/2026
Sartorius EUR 1.64B 280M Jun/2026
Sino Biopharmaceutical CNY 33.82B 9.13B Jun/2025
Takeda JPY 3.15T 59.77B Jun/2026
Tilray USD 729.32M 28.18M Sep/2025
Zealand Pharma A/S 15.02B 652.12M Mar/2026
Zz Pientze Pharmaceu CNY 11.43B 728.95M Mar/2026